ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Prescription Drug Costs. 180-Day Exclusivity. S.1114: Expanding Access to Low-Cost Generics Act of 2023. S.1128: Ensuring Access to Generic Medications Act. H.R.5461/S.2129: Ensuring Access to Lower-Cost Medicines for Seniors Act. H.R.4692/S.574: Increasing Prescription Drug Competition Act. H.R.1790: Biologics Competition Act of 2023. Labeling of Generic Drugs and Biosimilars. H.R.4134/S.2886: Updated Drug Labeling for Patient Safety Act Hickenlooper Safe Harbor for Skinny Labeling. S.775: Increasing Transparency in Generic Drug Applications Act. S.2510: RAPID Reserve Act. Drug Shortages. END Drug Shortages Act of 2023. Stop Drug Shortages Act. H.R.3008/S.2362: Drug Shortage Prevention Act of 2023. H.R. 3810: Drug Origin Transparency Act of 2023. Stockpile of Generic Drugs. Same Strength Requirement for Biosimilars. Biosimilar Red Tape Eliminations Act. Expediting Competitive Biosimilar Competition. FDA Inspections. Shaheen-Cassidy Citizen Petition Legislation. Guthrie Priority Review Voucher. Inflation Reduction Act (IRA) Implementation. H.R.3561: PATIENT Act of 2023. Trusted Partners in Medical Supply Chains. S.2364: MAPS Act. Dunn DeLauro Valisure and Department of Defense Agreement. H.R.3793: Ensuring Access to Lifesaving Drugs Act of 2023. H.R.167: Patient Access to Urgent-Use Pharmacy Compounding Act of 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRAIG BURTON | — |
| KARIN HESSLER | — |
| ILHAAM JAFFER New | Deputy Chief of Staff / Policy Adviser, U.S. Representative Eddie Bernice Johnson (TX-30); Advance Associate, The White House Office of Scheduling and Advance |
| PETER KELBEL | — |
| KATHERINE RAAB | — |
Medicare/Medicaid MMM
Medicare Part D Reform. Medicare Part D Program and Generic Drugs. Medicare Part D Low Income Subsidy (LIS) Program. Medicare Part D Coverage Gap Discount Program. Medicare Part D Tiering. H.R.5461/S.2129: Ensuring Access to Lower-Cost Medicines for Seniors Act. Medicare Reimbursement for Biosimilars. Medicaid Rebate Penalty. Rebates and Pharmacy Benefit Managers (PBMs). Medicare Price Negotiation. Medicare Advantage Proposed Rule. Inflation Reduction Act (IRA) Implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRAIG BURTON | — |
| KARIN HESSLER | — |
| ILHAAM JAFFER New | — |
| PETER KELBEL | — |
| KATHERINE RAAB | — |
Copyright/Patent/Trademark CPT
Skinny Labeling. Hickenlooper Safe Harbor for Skinny Labeling. REMEDY Act. IPR Amendments. H.R.4370/S.2220: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. Patent Listings in Orange Book. S.150: Affordable Prescriptions for Patients Act of 2023. S.2140: Patent Eligibility Restoration Act of 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN HESSLER | — |
| PETER KELBEL | — |
| KATHERINE RAAB | — |
Budget/Appropriations BUD
FDA Funding. Appropriations. Continuing Resolution.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN HESSLER | — |
| ILHAAM JAFFER New | — |
| PETER KELBEL | — |
| KATHERINE RAAB | — |
Trade (domestic/foreign) TRD
General Trade Issues. Drug Supply Chain. AAM Blueprint to Enhance the Security of the U.S. Supply Chain. Trusted Partners in Medical Supply Chains.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN HESSLER | — |
| ILHAAM JAFFER New | — |
| PETER KELBEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.